Limerick, Ireland

Marguerita Mccarthy

This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marguerita Mccarthy. Retrieved from https://idiyas.com/inventor/marguerita-mccarthy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marguerita Mccarthy: Innovator in Biopharmaceuticals

Introduction

Marguerita Mccarthy is a prominent inventor based in Limerick, Ireland. She has made significant contributions to the field of biopharmaceuticals, particularly in the characterization and purification of proteins. Her work is vital for advancing medical treatments and therapies.

Latest Patents

Marguerita holds a patent titled "Methods of Characterizing and Purifying VEGF Receptor Fusion Protein." This patent reflects her innovative approach to enhancing the efficacy of therapeutic proteins, which can lead to improved patient outcomes.

Career Highlights

Marguerita is currently employed at Regeneron Pharmaceuticals, Inc., a leading biopharmaceutical company known for its cutting-edge research and development. Her role at Regeneron allows her to collaborate with some of the brightest minds in the industry, contributing to groundbreaking advancements in medicine.

Collaborations

Throughout her career, Marguerita has worked alongside esteemed colleagues such as Paul Conroy and John Crowley. These collaborations have fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.

Conclusion

Marguerita Mccarthy's contributions to biopharmaceuticals exemplify the impact of innovative thinking in medicine. Her work continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…